Los Angeles, CA

The Los Angeles Headache Center

Migraine Disorders

Polyneuropathies

Neuralgia

Headache

DaxibotulinumtoxinA

LY3848575

Ki Health Partners

Lilly

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this study is to evaluate how safe and how well a treatment works compared to placebo for people with nerve pain that begins in their feet and moves up the leg to just below the knee.

Participation may last up to 30 weeks including screening.

Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

The Los Angeles Headache Center | Los Angeles, CA

Site insights

Work at this site?

Active trials

Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

Trial sponsors